KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biogen (BIIB) Cash from Investing Activities (2016 - 2025)

Historic Cash from Investing Activities for Biogen (BIIB) over the last 17 years, with Q4 2025 value amounting to -$1.2 billion.

  • Biogen's Cash from Investing Activities fell 652204.3% to -$1.2 billion in Q4 2025 from the same period last year, while for Dec 2025 it was -$1.4 billion, marking a year-over-year decrease of 7155.91%. This contributed to the annual value of -$1.4 billion for FY2025, which is 7155.91% down from last year.
  • As of Q4 2025, Biogen's Cash from Investing Activities stood at -$1.2 billion, which was down 652204.3% from -$35.1 million recorded in Q3 2025.
  • Biogen's 5-year Cash from Investing Activities high stood at $1.7 billion for Q3 2022, and its period low was -$1.7 billion during Q3 2023.
  • Over the past 5 years, Biogen's median Cash from Investing Activities value was -$126.9 million (recorded in 2021), while the average stood at -$262.9 million.
  • In the last 5 years, Biogen's Cash from Investing Activities surged by 81583.9% in 2022 and then crashed by 652204.3% in 2025.
  • Over the past 5 years, Biogen's Cash from Investing Activities (Quarter) stood at -$112.7 million in 2021, then dropped by 25.2% to -$141.1 million in 2022, then crashed by 362.3% to -$652.3 million in 2023, then soared by 97.15% to -$18.6 million in 2024, then tumbled by 6522.04% to -$1.2 billion in 2025.
  • Its last three reported values are -$1.2 billion in Q4 2025, -$35.1 million for Q3 2025, and -$57.0 million during Q2 2025.